63rd Annual Meeting of the Japanese Society of Neurology

Exhibitors

4 results  (1 - 4)

[ブースNo.17] AbbVie GK

AbbVie GK We will provide information of Duodopa that has been approved as a treatment for Parkinson's disease. We will exhibit not only drug information but also devices. We look forward to see you there.

[ブースNo.13] AMGEN.K.K

Headache diaries developed jointly by Japan Headache Society and LINE are displayed, focusing on “Aimovig, ” a drug for suppressing migraine attacks. Please do not hesitate to drop by. We sincerely...

[ブースNo.5] argenx Japan K.K.

argenx Japan K.K. イノベーションは、gMG※患者さんのために。
世界初、全身型重症筋無力症に対する抗FcRn抗体フラグメント製剤ウィフガート®についてご紹介致します。
ブースへのお立ち寄りを、心よりお待ち申し上げます。
※全身型重症筋無力症
JP-VJP-22-00237